JUYOUSHEN (JUC) FOR VAGINAL INFECTIONS DURING PREGNANCY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF EFFICACY, SAFETY, USABILITY, AND COST-EFFECTIVENESS
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Vaginal infections are common complications during pregnancy, associated with adverse maternal-fetal outcomes if untreated. Conventional treatments have limitations including systemic side effects, fetal risks, and high recurrence rates. Juyoushen (JUC), a long-acting physical antimicrobial material, has emerged as a promising alternative. This systematic review and meta-analysis aimed to comprehensively evaluate Juyoushen (JUC)’s efficacy, safety, usability, and cost-effectiveness for pregnancy-related vaginal infections. Methods: We integrated data from 12 high-quality studies (7 randomized controlled trials [RCTs] and 5 non-RCTs) involving 1,086 pregnant women. Efficacy indicators included total effective rate, cure rate, recurrence rate, and vaginal microecological recovery; safety was assessed via adverse reaction rates and fetal outcomes; usability and cost-effectiveness were compared with conventional treatments. Results: Juyoushen (JUC)’s total effective rate (97.2%) and cure rate (85.3%) were significantly higher than conventional treatments (91.5% and 72.3%, respectively; P < 0.001). Its recurrence rate (1.7%) was drastically lower than the control group (21.5%, P < 0.001), with superior lactobacilli recovery (89.6% vs. 72.8%, P < 0.001) and vaginal pH restoration (94.3% vs. 87.2%, P = 0.002). The adverse reaction rate of Juyoushen (JUC) (0.56%) was significantly lower than conventional treatments (18.7%, P < 0.001), with no fetal risks reported. Juyoushen (JUC) also demonstrated better usability (94%–95% adherence rate) and long-term cost-effectiveness. Conclusion: Juyoushen (JUC) is a safe, effective, user-friendly, and cost-effective first-line treatment for pregnancy-related bacterial vaginosis, vulvovaginal candidiasis, and mixed infections, worthy of widespread clinical promotion.
Fields of Study & Subjects
Reproductive tract infections research
Urinary Tract Infections Management
Traditional Chinese Medicine Clinical Research
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 1 April 2026
- Language
- EN